Pursuant to the "Code of Conduct" to regulate, monitor and report share trading by Designated Person and their immediate relative (''Code'') read with the application provisions of the ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has informed the stock exchanges that its Board of Directors will meet on Tuesday, October 28, 2025, to consider and approve the unaudited financial results along with the limited review report for the quarter and half year ended September 30, 2025. In compliance with insider trading regulations, the trading window for designated persons, insiders, connected persons, and their immediate relatives has been closed from Wednesday, October 01, 2025. The trading window will reopen 48 hours after the financial results are officially disclosed to the stock exchange.
This is a routine regulatory disclosure and not an actual insider trade. The trading window closure signals that Q2 FY26 results are forthcoming, which may influence near-term stock movement when announced on or after October 28, 2025. Shareholders should await the results for any fundamental insights.